ENGN analyst estimates

enGene Therapeutics (ENGN) analyst ratings, the average price target and its range, and every firm's latest call.

• 8 firms rate ENGN: 2 buy, 5 hold, 1 sell.
• The average price target is $3.00 from None analysts, from $2.00 to $4.00.

Updated 2026-11-12 17:46 UTC